Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,369,734 papers from all fields of science
Search
Sign In
Create Free Account
EMD 55900
Known as:
EMD 55 900
, Mab 425
A murine monoclonal antibody targeting the epidermal growth factor receptor (EGFR) exhibiting anti-tumor activity. EMD 55900 antibody binds to the…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
antigen binding
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
Dose-dependent access of murine anti-epidermal growth factor receptor monoclonal antibody to tumor cells in patients with advanced laryngeal and hypopharyngeal carcinoma
H. Bier
,
K. Reiffen
,
I. Haas
,
P. Stasiecki
European Archives of Oto-Rhino-Laryngology
2004
Corpus ID: 21165113
The murine IgG2a monoclonal antibody (mAb) EMD 55900 was produced against the human epidermoid carcinoma cell line A431, with…
Expand
2003
2003
Carcinomas unresponsive to either cisplatinum or anti-EGFR therapy can be growth inhibited by combination therapy of both agents.
R. Knecht
,
S. Peters
,
O. Adunka
,
K. Strebhardt
,
W. Gstoettner
,
M. Hambek
Anticancer Research
2003
Corpus ID: 25577153
BACKGROUND Previously we demonstrated that the antitumor efficacy of monoclonal antibodies against the EGFR (epidermal growth…
Expand
2002
2002
Anti‐epidermal growth factor receptor‐antibody therapy for treatment of breast cancer
C. Solbach
,
M. Roller
,
+6 authors
M. Kaufmann
International Journal of Cancer
2002
Corpus ID: 32072719
Recent studies demonstrated that tumors overexpressing the epidermal growth factor receptor (EGF‐R, erbB‐1) are associated with…
Expand
2001
2001
Tumor necrosis factor alpha sensitizes low epidermal growth factor receptor (EGFR)-expressing carcinomas for anti-EGFR therapy.
M. Hambek
,
C. Solbach
,
+5 authors
R. Knecht
Cancer Research
2001
Corpus ID: 44965747
Analysis of 1,060 xenotransplants derived from cancer cell lines as wel as spontaneously occurring tumors from the larynx…
Expand
2001
2001
Tumor Necrosis Factor a Sensitizes Low Epidermal Growth Factor Receptor ( EGFR )-expressing Carcinomas for Anti-EGFR Therapy 1
M. Hambek
,
C. Solbach
,
+5 authors
R. Knecht
2001
Corpus ID: 14399385
Analysis of 1060 xenotransplants derived from cancer cell lines as well as spontaneously occurring tumors from the larynx…
Expand
1997
1997
Growth inhibition of human papillary thyroid carcinoma cells and multicellular spheroids by anti-EGF-receptor antibody.
B. Gabler
,
T. Aicher
,
P. Heiss
,
R. Senekowitsch-Schmidtke
Anticancer Research
1997
Corpus ID: 20147371
EGF has been reported to stimulate thyroid cell proliferation. In the present study we investigated the effects of anti-EGF-R…
Expand
1994
1994
Improved uptake of 125i-mab 425 into high grade glioma cells by pretreatment with chloroquine and/or unlabeled mouse IGG: Possible therapeutic applications
R. Class
,
J. Emrich
,
C. Hand
,
D. Li
,
C. Miyamoto
,
L. Brady
1994
Corpus ID: 76272682
1993
1993
Finite proliferative lifespanin vitro of a human breast cancer cell strain isolated from a metastatic lymph node
Michael L. Mahacek
,
D. Beer
,
T. S. Frank
,
S. Ethier
Breast Cancer Research and Treatment
1993
Corpus ID: 25381632
SummaryWe recently described culture conditions that allow proliferation of metastatic human breast cancer cells from biopsy…
Expand
1993
1993
Biochemical and immunohistochemical detection of the epidermal growth-factor receptor (EGF-R) in breast-tumor specimens.
M. Beckmann
,
B. Tutschek
,
+5 authors
H. Bender
International Journal of Oncology
1993
Corpus ID: 13087726
Analyses of the level of expression of the epidermal growth factor receptor (EGF-R) of breast cancer tumors may add independent…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE